Health insurance companies are pushing physician ratings to steer more patients to what they see as less expensive but higher quality medical care. But doctors are finding these new measurements aren't always accurate. John Adams, a senior statistician at RAND Health in the Statistical Research and Consulting Group, tells host Bruce Japsen how doctor ratings are being used, their limitations, and their potetial impact as future quality measures.
Doctor Ratings Launch Amid Controversy, But are Here to Stay

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Health insurance companies are pushing physician ratings to steer more patients to what they see as less expensive but higher quality medical care. But doctors are finding these new measurements aren't always accurate. John Adams, a senior statistician at RAND Health in the Statistical Research and Consulting Group, tells host Bruce Japsen how doctor ratings are being used, their limitations, and their potetial impact as future quality measures.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
HF Management for Patients with Comorbid Conditions
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
AI and Hair Loss: Measuring Progress with Data-Driven Insights
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?